Logo
Login
$BCDA
$0.90 -$0.02 (2.33%) After hours

Company Executives

$BCDA Management Team

Mr. Andrew Blank

Independent Chairman of the Board

Age 69
Compensation $95.47K USD
Sex Male

Dr. Peter Altman

President

Chief Executive Officer

Director

Age 59
Compensation $493.4K USD
Sex Male

Mr. David Mcclung

Chief Financial Officer

Age 62
Compensation $354.9K USD
Sex Male

Mr. Edward Gillis

Senior Vice President - Devices

Age 63
Compensation $251.8K USD
Sex Male

Board of Directors

From the proxy statement filed Nov 3, 2025
Directors
6
serving now
Independent
0 of 1
stated in the proxy; 5 not stated
Average tenure
Not stated
from year joined
CEO also chairs the board
Not stated
no chair stated
Director Age On board Independent Committees Other public boards 2024 pay Source
Altman
Not stated Not stated Not independent None stated None stated Not stated
Jay Moyes
Not stated Not stated Not stated
Audit Committee · Chair
None stated $62,966
Richard Krasno, Ph.D.
Not stated Not stated Not stated None stated None stated $55,466
Bill Facteau
Not stated Not stated Not stated None stated None stated $49,466
Andrew Blank
Not stated Not stated Not stated
Compensation Committee · Chair Nominating and Corporate Governance Committee · Chair
None stated $95,466
Jim Allen
Not stated Not stated Not stated None stated None stated $46,966
Nominated to join at the meeting
Not on the board yet; they join only if elected.

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

23 disclosed in the proxy filed Nov 3, 2025
BSLF, L.L.C.
an entity owned and controlled by Andrew Blank, a member of our board of directors
$112,876
2024

Company remitted litigation service credits to BSLF under the settlement of the Litigation Funding Agreement

With the Company Open in proxy
Peter Altman
President, Chief Executive Officer, and a member of our board of directors
$50,000
February 2024

Purchased common stock and warrants in the February 2024 private placement

With the Company Open in proxy
Thomas A. Satterfield, Jr.
a holder of 5% stockholder
$210,000
August 2024

Entities affiliated with him invested in the August 2024 registered offering

With the Company Open in proxy
Andrew Blank
a member of our board of directors
$333,000
August 2024

Invested in the August 2024 registered offering

With the Company Open in proxy
Jim Allen
a member of our board of directors
$150,000
August 2024

Invested in the August 2024 registered offering

With the Company Open in proxy
Peter Altman
President, Chief Executive Officer, and a member of our board of directors
$125,000
August 2024

Invested in the August 2024 registered offering

With the Company Open in proxy
David McClung
Chief Financial Officer
$25,000
August 2024

Invested in the August 2024 registered offering

With the Company Open in proxy
Thomas A. Satterfield, Jr.
a holder of 5% stockholder
$150,000
April 2025

Entities affiliated with him invested in the April 2025 private placement

With the Company Open in proxy
Andrew Blank
a member of our board of directors
$250,000
April 2025

Invested in the April 2025 private placement

With the Company Open in proxy
Simon H. Stertzer, M.D.
a member of our board of directors
$200,000
April 2025

Invested in the April 2025 private placement

With the Company Open in proxy
Bill Facteau
a member of our board of directors
$25,000
April 2025

Invested in the April 2025 private placement

With the Company Open in proxy
Peter Altman
President, Chief Executive Officer, and a member of our board of directors
$50,000
April 2025

Invested in the April 2025 private placement

With the Company Open in proxy
David McClung
Chief Financial Officer
$25,000
April 2025

Invested in the April 2025 private placement

With the Company Open in proxy
Thomas A. Satterfield, Jr.
a holder of 5% stockholder
$100,000
June 2025

Entities affiliated with him invested in the June 2025 private placement

With the Company Open in proxy
Andrew Blank
a member of our board of directors
$150,000
June 2025

Invested in the June 2025 private placement

With the Company Open in proxy
Simon H. Stertzer, M.D.
a member of our board of directors
$150,000
June 2025

Invested in the June 2025 private placement

With the Company Open in proxy
Peter Altman
President, Chief Executive Officer, and a member of our board of directors
$50,000
June 2025

Invested in the June 2025 private placement

With the Company Open in proxy
David McClung
Chief Financial Officer
$10,000
June 2025

Invested in the June 2025 private placement

With the Company Open in proxy
Thomas A. Satterfield, Jr.
a holder of 5% stockholder
$500,000
September 2025

Entities affiliated with him invested in the September 2025 offering

With the Company Open in proxy
Andrew Blank
a member of our board of directors
$360,000
September 2025

Invested in the September 2025 offering

With the Company Open in proxy
Simon H. Stertzer, M.D.
a member of our board of directors
$498,000
September 2025

Invested in the September 2025 offering

With the Company Open in proxy
Peter Altman
President, Chief Executive Officer, and a member of our board of directors
$60,000
September 2025

Invested in the September 2025 offering

With the Company Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans